Quipt Home Medical Corp. (QIPT)
USD 2.02
(-8.18%)
USD 2.02
(-8.18%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 163.84 Million USD | 53.63% |
| 2022 | 106.64 Million USD | 43.77% |
| 2021 | 74.17 Million USD | 39.99% |
| 2020 | 52.98 Million CAD | 22.12% |
| 2019 | 43.39 Million CAD | 4.76% |
| 2018 | 41.41 Million CAD | -5.05% |
| 2017 | 43.62 Million CAD | -41.16% |
| 2016 | 74.13 Million CAD | 111.57% |
| 2015 | 35.04 Million CAD | 187.7% |
| 2014 | 12.17 Million CAD | 382.8% |
| 2013 | 2.52 Million CAD | -5.44% |
| 2012 | 2.66 Million CAD | 222.24% |
| 2011 | 827.86 Thousand CAD | 31105.99% |
| 2010 | -2670.00 CAD | -196.39% |
| 2009 | 2770.00 CAD | -95.3% |
| 2008 | 58.94 Thousand CAD | -92.33% |
| 2007 | 768.43 Thousand CAD | -9.04% |
| 2006 | 844.84 Thousand CAD | 71.4% |
| 2005 | 492.9 Thousand CAD | -84.05% |
| 2004 | 3.09 Million CAD | 36.8% |
| 2003 | 2.25 Million CAD | 32.63% |
| 2002 | 1.7 Million CAD | 49.9% |
| 2001 | 1.13 Million CAD | 683.61% |
| 2000 | 145.01 Thousand CAD | 0.0% |
| 1999 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 35.15 Million USD | -0.38% |
| 2024 Q3 | 34.8 Million USD | -0.03% |
| 2024 Q1 | 36.09 Million USD | 2.65% |
| 2023 FY | 163.84 Million USD | 53.63% |
| 2023 Q3 | 43.65 Million USD | 1.03% |
| 2023 Q4 | 46.24 Million USD | 5.92% |
| 2023 Q2 | 43.21 Million USD | 40.57% |
| 2023 Q1 | 30.74 Million USD | -0.19% |
| 2022 Q4 | 30.79 Million USD | 10.84% |
| 2022 Q1 | 21.86 Million USD | 4.7% |
| 2022 FY | 106.64 Million USD | 43.77% |
| 2022 Q2 | 26.19 Million USD | 19.82% |
| 2022 Q3 | 27.78 Million USD | 6.06% |
| 2021 FY | 74.17 Million USD | 39.99% |
| 2021 Q2 | 18.11 Million USD | 8.6% |
| 2021 Q3 | 18.49 Million USD | 2.06% |
| 2021 Q4 | 20.88 Million USD | 12.94% |
| 2021 Q1 | 16.68 Million USD | 16.25% |
| 2020 Q4 | 14.35 Million CAD | 6.34% |
| 2020 FY | 52.98 Million CAD | 22.12% |
| 2020 Q2 | 12.4 Million CAD | -3.17% |
| 2020 Q1 | 12.81 Million CAD | 52.16% |
| 2020 Q3 | 13.49 Million CAD | 8.75% |
| 2019 Q1 | 11.42 Million CAD | 3.64% |
| 2019 Q2 | 11.65 Million CAD | 1.97% |
| 2019 FY | 43.39 Million CAD | 4.76% |
| 2019 Q3 | 11.26 Million CAD | -3.33% |
| 2019 Q4 | 8.42 Million CAD | -25.22% |
| 2018 Q3 | 10.47 Million CAD | -0.18% |
| 2018 Q4 | 11.02 Million CAD | 5.24% |
| 2018 FY | 41.41 Million CAD | -5.05% |
| 2018 Q1 | 10.05 Million CAD | 165.99% |
| 2018 Q2 | 10.49 Million CAD | 4.38% |
| 2017 Q4 | -15.23 Million CAD | -174.69% |
| 2017 Q1 | 18.03 Million CAD | 0.93% |
| 2017 Q3 | 20.39 Million CAD | 5.55% |
| 2017 FY | 43.62 Million CAD | -41.16% |
| 2017 Q2 | 19.32 Million CAD | 7.13% |
| 2016 Q3 | 18 Million CAD | 0.98% |
| 2016 Q1 | 18.79 Million CAD | 52.38% |
| 2016 FY | 74.13 Million CAD | 111.57% |
| 2016 Q4 | 17.87 Million CAD | -0.74% |
| 2016 Q2 | 17.82 Million CAD | -5.12% |
| 2015 FY | 35.04 Million CAD | 187.7% |
| 2015 Q2 | 6.73 Million CAD | 9.02% |
| 2015 Q4 | 12.33 Million CAD | 22.76% |
| 2015 Q3 | 10.04 Million CAD | 49.1% |
| 2015 Q1 | 6.18 Million CAD | 5.38% |
| 2014 Q4 | 5.86 Million CAD | 85.55% |
| 2014 FY | 12.17 Million CAD | 382.8% |
| 2014 Q3 | 3.16 Million CAD | 49.99% |
| 2014 Q1 | 972.45 Thousand CAD | 41.6% |
| 2014 Q2 | 2.1 Million CAD | 116.71% |
| 2013 Q2 | 602.47 Thousand CAD | -15.79% |
| 2013 Q4 | 686.74 Thousand CAD | 19.04% |
| 2013 FY | 2.52 Million CAD | -5.44% |
| 2013 Q3 | 576.9 Thousand CAD | -4.24% |
| 2013 Q1 | 715.42 Thousand CAD | -10.02% |
| 2012 Q2 | 603.69 Thousand CAD | 8.22% |
| 2012 Q4 | 795.08 Thousand CAD | 10.36% |
| 2012 Q3 | 720.46 Thousand CAD | 19.34% |
| 2012 FY | 2.66 Million CAD | 222.24% |
| 2012 Q1 | 557.82 Thousand CAD | 61.11% |
| 2011 Q3 | 284.77 Thousand CAD | 92.29% |
| 2011 FY | 827.86 Thousand CAD | 31105.99% |
| 2011 Q1 | 46.69 Thousand CAD | 999.61% |
| 2011 Q2 | 148.09 Thousand CAD | 217.14% |
| 2011 Q4 | 346.24 Thousand CAD | 21.59% |
| 2010 Q4 | -5191.00 CAD | -305.94% |
| 2010 Q1 | -63.89 Thousand CAD | -30.64% |
| 2010 Q2 | -61.65 Thousand CAD | 3.5% |
| 2010 FY | -2670.00 CAD | -196.39% |
| 2010 Q3 | 2520.63 CAD | 104.09% |
| 2009 FY | 2770.00 CAD | -95.3% |
| 2009 Q4 | -48.91 Thousand CAD | -287.3% |
| 2009 Q3 | 26.11 Thousand CAD | 185.85% |
| 2009 Q2 | -30.41 Thousand CAD | -803.65% |
| 2009 Q1 | -3366.00 CAD | -127.35% |
| 2008 Q3 | -2.18 Million CAD | -403.92% |
| 2008 Q2 | 717.59 Thousand CAD | -8.16% |
| 2008 Q1 | 781.37 Thousand CAD | 387.63% |
| 2008 FY | 58.94 Thousand CAD | -92.33% |
| 2008 Q4 | 12.3 Thousand CAD | 100.56% |
| 2007 FY | 768.43 Thousand CAD | -9.04% |
| 2007 Q4 | 160.23 Thousand CAD | 111.63% |
| 2007 Q3 | -1.37 Million CAD | -290.22% |
| 2007 Q2 | 724.01 Thousand CAD | -5.84% |
| 2007 Q1 | 768.91 Thousand CAD | 406.44% |
| 2006 FY | 844.84 Thousand CAD | 71.4% |
| 2006 Q2 | 729.87 Thousand CAD | 5.47% |
| 2006 Q1 | 692.02 Thousand CAD | 564.78% |
| 2006 Q3 | -1.27 Million CAD | -274.15% |
| 2006 Q4 | 151.82 Thousand CAD | 111.94% |
| 2005 FY | 492.9 Thousand CAD | -84.05% |
| 2005 Q1 | 641.97 Thousand CAD | -17.09% |
| 2005 Q2 | 652.56 Thousand CAD | 1.65% |
| 2005 Q3 | -1.6 Million CAD | -345.93% |
| 2005 Q4 | 104.09 Thousand CAD | 106.49% |
| 2004 Q2 | 815.28 Thousand CAD | -13.95% |
| 2004 Q3 | 787.19 Thousand CAD | -3.44% |
| 2004 Q4 | 774.28 Thousand CAD | -1.64% |
| 2004 FY | 3.09 Million CAD | 36.8% |
| 2004 Q1 | 947.39 Thousand CAD | 781.05% |
| 2003 Q1 | 469.22 Thousand CAD | 274.72% |
| 2003 FY | 2.25 Million CAD | 32.63% |
| 2003 Q4 | 107.53 Thousand CAD | -84.74% |
| 2003 Q3 | 704.7 Thousand CAD | 28.28% |
| 2003 Q2 | 549.32 Thousand CAD | 17.07% |
| 2002 Q1 | 394.58 Thousand CAD | 2.3% |
| 2002 FY | 1.7 Million CAD | 49.9% |
| 2002 Q3 | 470.75 Thousand CAD | 6.65% |
| 2002 Q4 | 125.22 Thousand CAD | -73.4% |
| 2002 Q2 | 441.38 Thousand CAD | 11.86% |
| 2001 Q4 | 385.7 Thousand CAD | 0.0% |
| 2001 FY | 1.13 Million CAD | 683.61% |
| 2000 FY | 145.01 Thousand CAD | 0.0% |
| 1999 FY | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -6325.294% |
| BrainsWay Ltd. | 23.09 Million USD | -609.562% |
| Cerus Corporation | 86.4 Million USD | -89.635% |
| Envoy Medical, Inc. | -473 Thousand USD | 34739.535% |
| electroCore, Inc. | 13.22 Million USD | -1138.81% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -268498.361% |
| IceCure Medical Ltd | 1.3 Million USD | -12503.462% |
| Inogen, Inc. | 126.69 Million USD | -29.318% |
| OrthoPediatrics Corp. | 111.25 Million USD | -47.272% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 2808.182% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 346231.908% |
| MaxCyte, Inc. | 36.54 Million USD | -348.325% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -35790.23% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -192522.854% |
| Orthofix Medical Inc. | 486.27 Million USD | 66.306% |
| PAVmed Inc | -3.96 Million USD | 4229.158% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 3087.147% |
| RxSight, Inc. | 53.76 Million USD | -204.743% |
| Sight Sciences, Inc. | 69.17 Million USD | -136.856% |
| SI-BONE, Inc. | 109.42 Million USD | -49.74% |
| TELA Bio, Inc. | 40.11 Million USD | -308.469% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | -7.837% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -1880.958% |
| Acutus Medical, Inc. | -3.13 Million USD | 5322.984% |
| Talis Biomedical Corporation | 371 Thousand USD | -44063.073% |
| Spectral AI, Inc. | 7.88 Million USD | -1979.251% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 2585.513% |
| CVRx, Inc. | 33.03 Million USD | -395.914% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -22055.408% |
| Bioventus Inc. | 328.19 Million USD | 50.077% |
| Venus Concept Inc. | 52.16 Million USD | -214.078% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -930.083% |
| LivaNova PLC | 771.25 Million USD | 78.756% |
| 908 Devices Inc. | 25.32 Million USD | -547.046% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 47.181% |
| Nemaura Medical Inc. | -1.47 Million USD | 11197.662% |
| NeuroPace, Inc. | 48.12 Million USD | -240.478% |
| LENSAR, Inc. | 21.1 Million USD | -676.259% |
| Apyx Medical Corporation | 14.12 Million USD | -1060.211% |
| Cutera, Inc. | 41.49 Million USD | -294.864% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -787.52% |
| BioSig Technologies, Inc. | 18 Thousand USD | -910150.0% |
| Anika Therapeutics, Inc. | 103.08 Million USD | -58.937% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -1103.504% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 81.557% |
| Axonics, Inc. | 274.55 Million USD | 40.323% |
| Outset Medical, Inc. | 29 Million USD | -464.983% |
| IRIDEX Corporation | 21.8 Million USD | -651.341% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | -130.608% |
| IRadimed Corporation | 50.15 Million USD | -226.656% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -56988.85% |
| INVO Bioscience, Inc. | 1.08 Million USD | -14985.1% |
| Telesis Bio, Inc. | 16.95 Million USD | -866.637% |
| Viemed Healthcare, Inc. | 112.78 Million USD | -45.275% |
| Varex Imaging Corporation | 256.9 Million USD | 36.222% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 40455.911% |
| Pulmonx Corporation | 50.75 Million USD | -222.835% |
| Dynatronics Corporation | 7.63 Million USD | -2045.979% |
| Modular Medical, Inc. | -768 Thousand USD | 21433.984% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -2853.226% |
| Semler Scientific, Inc. | 61.2 Million USD | -167.721% |
| InMode Ltd. | 411.34 Million USD | 60.168% |
| Bruker Corporation | 1.51 Billion USD | 89.198% |
| Cytosorbents Corporation | 22.39 Million USD | -631.711% |
| DexCom, Inc. | 2.28 Billion USD | 92.842% |
| Align Technology, Inc. | 2.71 Billion USD | 93.973% |
| Viveve Medical, Inc. | 620 Thousand USD | -26326.613% |
| ZimVie Inc. | 290.38 Million USD | 43.576% |
| Movano Inc. | -158 Thousand USD | 103799.367% |
| Cytek Biosciences, Inc. | 109.42 Million USD | -49.731% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -192522.854% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 55.439% |
| Profound Medical Corp. | 4.51 Million USD | -3529.691% |
| Insulet Corporation | 1.15 Billion USD | 85.874% |
| enVVeno Medical Corporation | -546 Thousand USD | 30108.242% |
| Surmodics, Inc. | 93.05 Million USD | -76.079% |
| iCAD, Inc. | 14.53 Million USD | -1027.167% |
| Nuwellis, Inc. | 4.98 Million USD | -3188.079% |
| Biotricity, Inc. | 8.35 Million USD | -1860.741% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 50.62% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 45732.031% |
| InspireMD, Inc. | 1.8 Million USD | -8967.239% |
| PAVmed Inc. | -3.96 Million USD | 4229.158% |
| BIOLASE, Inc. | 16.72 Million USD | -879.7% |
| Beyond Air, Inc. | -1.3 Million USD | 12635.96% |
| FONAR Corporation | 45.14 Million USD | -262.97% |
| AxoGen, Inc. | 127.87 Million USD | -28.13% |
| Vivani Medical, Inc. | -357 Thousand USD | 45994.958% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 16.034% |
| Inari Medical, Inc. | 434.56 Million USD | 62.297% |
| UFP Technologies, Inc. | 112.22 Million USD | -45.997% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -1308670.669% |
| Tenon Medical, Inc. | 1.24 Million USD | -13102.659% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 202377.778% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -6136.751% |
| AdaptHealth Corp. | 479.56 Million USD | 65.835% |
| Sintx Technologies, Inc. | 1.84 Million USD | -8790.125% |
| NanoVibronix, Inc. | 1.53 Million USD | -10560.052% |
| Quanterix Corporation | 70.64 Million USD | -131.924% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 40455.911% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -1065.327% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | -210.43% |
| TransMedics Group, Inc. | 154.09 Million USD | -6.329% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -3579.43% |
| NeuroMetrix, Inc. | 3.94 Million USD | -4050.693% |
| Hyperfine, Inc. | 4.75 Million USD | -3344.293% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | -53.159% |
| Biomerica, Inc. | 611 Thousand USD | -26715.876% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | -293.033% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 21080.082% |
| Silk Road Medical, Inc | 127.08 Million USD | -28.925% |